Penumbra Reports Second Quarter 2017 Financial Results

Published: Aug 09, 2017

ALAMEDA, Calif., Aug. 8, 2017 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on interventional therapies, today reported financial results for the second quarter ended June 30, 2017.

Revenue of $80.6 million in the second quarter of 2017, an increase of 23.8%, or 24.6% in constant currency1, over the second quarter of 2016.

Back to news